Publications
Original Article
The Immune Landscape of Cancer
2018
Authors:
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I
Journal:
Immunity
Volume:
48(4)
Page:
812-830
Review Article
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
2018
Authors:
Butterfield LH, Disis ML, Fox BA, Kaufman DR, Khleif SN, Wang E; Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers.
Journal:
Journal of Immunotherapy Cancer
Volume:
6(1)
Page:
138
Review Article
Next generation approaches for tumor vaccination
Cancer Vaccines
2017
Authors:
Patel A, Kaufman HL, Disis ML.
Journal:
Chinese Clinical Oncology
Volume:
6(2)
Page:
19
Original Article
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
T Cell Function & Therapy
2017
Authors:
Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, Mihalik LA, Dang Y, Disis ML, Cohen PA.
Journal:
Oncotarget
Volume:
8(7)
Page:
10785-10808
Review Article
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer
Cancer Vaccines
2017
Authors:
Watt WC, Cecil DL, Disis ML.
Journal:
Seminars in Immunopathology
Volume:
39(3)
Page:
245-253
Original Article
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial
Tumor Microenvironment
2017
Authors:
Salazar, LG, Lu, H, Reichow, JL, Childs, JS, Coveler, AL, Higgins, DM, Waisman, J, Allison, KH, Dang, Y, and Disis, ML
Journal:
JAMA Oncology
Volume:
3(7)
Page:
969-973
Original Article
Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo
Cancer Vaccines
2017
Authors:
Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.
Journal:
Clinical Cancer Research
Volume:
23(13)
Page:
3396-3404
Review Article
Precancer Atlas to Drive Precision Prevention Trials
2017
Authors:
Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM.
Journal:
Cancer Research
Volume:
77(7)
Page:
1510-1541
Review Article
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Measuring Human Immunity
2017
Authors:
Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.
Journal:
Journal of Immunotherapy of cancer
Volume:
5
Page:
44
Original Article
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
Clinical Trials
2017
Authors:
John B Liao, Ron E Swensen , Kelsie J Ovenell , Katie M Hitchcock-Bernhardt, Jessica L Reichow, Minjun C Apodaca, Leonard D'Amico, Jennifer S Childs, Doreen M Higgins, Barbara J Buening, Barbara A Goff, Mary L Disis
Journal:
Gynecologic Oncology
Volume:
144(3)
Page:
480-485